Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 CAD | -3.33% |
|
-6.45% | -28.40% |
Jun. 05 | DIAGNOS Raises $0.98 Million in the Second and Final Tranche of a Private Placement of Share Units | MT |
Jun. 05 | DIAGNOS Inc. announced that it has received CAD 1.295821 million in funding | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 12.07 | 6.388 | 11.97 | 35.98 | 17.37 | 24.36 |
Enterprise Value (EV) 1 | 16.42 | 11.26 | 10.43 | 35.09 | 17.63 | 26.37 |
P/E ratio | -4.08 x | -1.47 x | -2.35 x | -16.6 x | -6.59 x | -9.68 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 9.34 x | 19.6 x | 36.1 x | 135 x | 39.6 x | 50.2 x |
EV / Revenue | 12.7 x | 34.5 x | 31.5 x | 131 x | 40.2 x | 54.3 x |
EV / EBITDA | -6.59 x | -4.11 x | -3.85 x | -15.7 x | -6.71 x | -12 x |
EV / FCF | -7.77 x | -6.29 x | -4.53 x | -41.8 x | -14.6 x | -21.6 x |
FCF Yield | -12.9% | -15.9% | -22.1% | -2.39% | -6.84% | -4.63% |
Price to Book | -3.32 x | -1.26 x | 6.58 x | 32.1 x | -153 x | -12.5 x |
Nbr of stocks (in thousands) | 17,242 | 21,293 | 61,366 | 66,626 | 69,474 | 70,611 |
Reference price 2 | 0.7000 | 0.3000 | 0.1950 | 0.5400 | 0.2500 | 0.3450 |
Announcement Date | 7/27/18 | 6/27/19 | 6/5/20 | 6/8/21 | 7/13/22 | 7/13/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1.293 | 0.3265 | 0.3315 | 0.2671 | 0.4388 | 0.4857 |
EBITDA 1 | -2.493 | -2.739 | -2.71 | -2.239 | -2.626 | -2.203 |
EBIT 1 | -2.714 | -2.93 | -2.796 | -2.283 | -2.66 | -2.237 |
Operating Margin | -209.96% | -897.47% | -843.5% | -854.98% | -606.14% | -460.53% |
Earnings before Tax (EBT) 1 | -3.961 | -3.904 | -3.383 | -2.051 | -2.608 | -2.481 |
Net income 1 | -2.897 | -3.839 | -3.383 | -2.051 | -2.608 | -2.481 |
Net margin | -224.1% | -1,175.93% | -1,020.42% | -768.07% | -594.35% | -510.72% |
EPS 2 | -0.1716 | -0.2038 | -0.0830 | -0.0325 | -0.0379 | -0.0356 |
Free Cash Flow 1 | -2.114 | -1.792 | -2.303 | -0.8398 | -1.207 | -1.222 |
FCF margin | -163.55% | -548.83% | -694.75% | -314.44% | -274.96% | -251.51% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/27/18 | 6/27/19 | 6/5/20 | 6/8/21 | 7/13/22 | 7/13/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 0.0809 | 0.1298 | 0.1521 | 0.149 | 0.1465 | 0.1219 | 0.0683 | 0.0433 | 0.0327 | 0.0521 |
EBITDA 1 | -0.6221 | -0.5996 | -0.7122 | -0.6776 | -0.4744 | -0.4472 | -0.5567 | -0.6409 | -0.6173 | -0.6789 |
EBIT | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 10/27/21 | 2/28/22 | 7/13/22 | 8/25/22 | 11/29/22 | 1/25/23 | 7/13/23 | 8/24/23 | 11/28/23 | 2/28/24 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 4.35 | 4.87 | - | - | 0.26 | 2.01 |
Net Cash position 1 | - | - | 1.54 | 0.89 | - | - |
Leverage (Debt/EBITDA) | -1.747 x | -1.779 x | - | - | -0.1003 x | -0.9113 x |
Free Cash Flow 1 | -2.11 | -1.79 | -2.3 | -0.84 | -1.21 | -1.22 |
ROE (net income / shareholders' equity) | 115% | 88.1% | 207% | -139% | -512% | 241% |
ROA (Net income/ Total Assets) | -120% | -134% | -96% | -65.1% | -95.2% | -118% |
Assets 1 | 2.419 | 2.863 | 3.524 | 3.151 | 2.739 | 2.098 |
Book Value Per Share 2 | -0.2100 | -0.2400 | 0.0300 | 0.0200 | -0 | -0.0300 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0 |
Capex 1 | 0.27 | 0.04 | 0.02 | 0.04 | 0.03 | 0.02 |
Capex / Sales | 20.96% | 12.95% | 4.56% | 15.79% | 7.07% | 4.99% |
Announcement Date | 7/27/18 | 6/27/19 | 6/5/20 | 6/8/21 | 7/13/22 | 7/13/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-28.40% | 17.32M | |
-14.66% | 188B | |
+5.30% | 173B | |
+8.62% | 163B | |
+0.20% | 95.54B | |
+53.03% | 95.08B | |
+15.59% | 85.84B | |
+7.64% | 82.44B | |
+4.90% | 49.75B | |
-28.86% | 47.4B |
- Stock Market
- Equities
- ADK Stock
- Financials DIAGNOS Inc.